What researchers published on Áttétes emlőrák
30 315 papers, newest first.
Showing 80 of 30 315
Identifying Distant Breast Cancer Recurrence: A Proof-of-Concept Comparison of Discrete-Field Algorithm and Large Language Model Performance and Cost.JCO clinical cancer informatics
Single-cell multiomics profiling reveals tumour microenvironment landscape and sex-specific immune-suppressive feature in male breast cancer.Clinical and translational medicine
Comparison of five definitions of meaningful change on patient-reported outcomes in four SWOG clinical trials.Journal of patient-reported outcomes
ÁttekintésERα-Targeting PROTACs in Breast Cancer: Structural Design, Biological Mechanisms, Clinical Translation, and Implications for Multimodal Management.Critical reviews in oncology/hematology
Exploring women's perceptions of climate-related environmental stressors and their influence on palliative care experiences and quality of life among women with breast cancer in Ghana: a qualitative descriptive study.BMC palliative care
Dual-database pharmacovigilance analysis based on FAERS and JADER combined with network pharmacology to explore fulvestrant-associated respiratory toxicity.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Advanced Breast Cancer Patients Treated with Trastuzumab Deruxtecan: A Real-World Study.Journal of clinical medicine
MetaanalízisSurvival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.Breast cancer research and treatment
Real-World Implementation of Molecular Testing and Biomarker-Guided Therapies in HR+/HER2- Metastatic Breast Cancer.Cancers
Time to maximal response of trastuzumab deruxtecan in patients with HER2-Positive metastatic breast cancer: A multicenter retrospective study (TRACE).Breast (Edinburgh, Scotland)
Early Magnetic Resonance Imaging and Single-Photon Emission Computerized Tomography Detection of Breast Cancer With Netrin-1-Specific Molecular and Liposome Probes.ChemMedChem
An EO771-Derived Metastatic Breast Cancer Model Exhibits RANKL-Associated Osteoimmune Remodeling Before Detectable Bone-Marrow Dissemination.Biology
ÁttekintésRechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors.Breast cancer research and treatment
Prognostic Value of Metabolic-Muscle Reserve Index in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.Journal of clinical medicine
Survival Differences Between De Novo and Recurrent HER2-Positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.Oncology
A Novel Function of Tubulin β2a and Tubulin β3 in Regulating Metastatic Properties in Bone-Metastatic Breast Cancer Cells.Cancers
ÁttekintésNavigating treatment for De novo oligometastatic breast cancer: The Assisi think tank meeting.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
KLRB1 (CD161) as a context-dependent prognostic marker in breast cancer: An exploratory analysis of CD4+ memory T cell infiltration: a retrospective multi-cohort study.Medicine
Addition of tucatinib to trastuzumab/pertuzumab after local therapy for isolated intracranial progression in HER2-positive metastatic breast cancer: primary results of the phase II BRIDGET trial.ESMO open
Pyramid-level training with stain normalization for breast cancer lymph-node metastasis segmentation in whole-slide images.PloS one
Phosphatidylserine modulation influences syncytia formation in human breast cancer cell lines.BMC cancer
EsetismertetésCase report: Fournier's gangrene occurring after inavolisib-induced hyperglycemia in a patient with metastatic breast cancer.Frontiers in pharmacology
Otological manifestations of disseminated metastatic breast cancer presenting with facial nerve palsy, tinnitus and otalgia.BMJ case reports
Metachronous gastric adenocarcinoma during sustained control of metastatic breast cancer.Revista espanola de enfermedades digestivas
ÁttekintésCellular/Molecular-assisted Early Detection of Breast Cancer: An Update.Anti-cancer agents in medicinal chemistry
CT-defined sarcopenia and outcomes in HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors.Frontiers in medicine
Cost-effectiveness of inavolisib plus palbociclib/fulvestrant versus palbociclib/fulvestrant for PIK3CA-mutated advanced breast cancer in China.Frontiers in pharmacology
Palbociclib, Fulvestrant, Trastuzumab, and Pyrotinib for Patients with Advanced Breast Cancer with Brain Metastases: A Prospective Multicenter Phase 2 Trial.Clinical cancer research : an official journal of the American Association for Cancer Research
Patterns of metastasis according to germline BRCA1/2 mutation status in patients with HER2-negative metastatic breast cancer.Breast cancer research : BCR
Ultra-sensitive MRD assessment in long-term complete responders to anti-HER2 therapy in HER2-positive metastatic breast cancer: initial results from HER2-CR study.ESMO open
Effect of different axillary management strategies on survival in elderly patients (≥70 Years) with early-stage breast cancer and 1-2 positive lymph nodes, stratified by risk factors.PloS one
High-Purity Magnetic Fluidic Isolation of Viable Circulating Tumor Cells Enables Single-Cell Multi-Omics Profiling.Analytical chemistry
Potential prognostic value of the free T3/T4 ratio in HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.BMC cancer
Interpreting EORTC CAT Core short-form scores in metastatic breast cancer: EQ-VAS-associated cut-points and comparison with published thresholds for clinical importance.Journal of patient-reported outcomes
Analytical and clinical validation of Ion Torrent™ Oncomine™ Dx Express Test for identifying PIK3CA/AKT1/PTEN-altered tumors in patients with hormone receptor-positive advanced breast cancer for treatment with capivasertib.Translational oncology
CD39-associated myeloid-T-cell coordination within an immunoregulatory neighborhood linked to treatment resistance in triple-negative breast cancer.Breast cancer research : BCR
Real-world outcomes of everolimus-based therapy after CDK4/6 inhibitor therapy in ER-positive/HER2-negative metastatic breast cancer: a multicenter registry-based study.Breast cancer (Tokyo, Japan)
EsetismertetésBreast metastasis from BRCA1-mutated ovarian cancer: response to parp inhibition and a potential lymphatic route.BMC women's health
Dual Primary Malignancies in Breast Cancer: Clinical Characteristics and Survival Predictors Among Hakka Women in Meizhou.Breast cancer (Dove Medical Press)
EsetismertetésSequential Anti-HER2 (Human Epidermal Growth Factor Receptor 2) Therapy and Late-Line Tucatinib in Patients With HER2-Positive Breast Cancer and Brain Metastases: A Real-World Case Report.Cureus
TP53 shapes tumour-specific immune phenotypes across breast, colorectal and kidney human cancers.Journal of molecular medicine (Berlin, Germany)
ÁttekintésMechanotransduction in breast cancer and implications for preclinical modeling.Cancer metastasis reviews
FOSL2 expression in histologically diagnosed breast cancer: first immunohistochemical evidence from Cameroon.BMC cancer
EsetismertetésExperience with pyrotinib monotherapy for advanced HER2-positive breast cancer with diffuse hepatic metastases and severe hepatic dysfunction: a case report.International journal of surgery case reports
ÁttekintésMitochondrial Calcium Signaling Acts in the Regulation of Quiescence in Estrogen Receptor-Positive Breast Cancer.The Yale journal of biology and medicine
Glycolipid-lectin driven endocytosis as a therapeutic vulnerability in breast cancer.Signal transduction and targeted therapy
MetaanalízisSequencing trastuzumab deruxtecan and sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis.European journal of clinical pharmacology
Molecular and clinical predictors of NAC response and relapse in HR+/HER2- early breast cancer.Breast cancer research : BCR
EsetismertetésSuccessful Trastuzumab Desensitization After a Severe Infusion-Related Reaction with Acute Hypoxemia and Suspected Pulmonary Toxicity in HER2-Positive Metastatic Breast Cancer: A Case Report.Cancer management and research
MetaanalízisPertuzumab in HER2-positive breast cancer: a systematic review and meta-analysis of randomized controlled trials.Breast cancer research and treatment
Chemoendocrine therapy versus tamoxifen with ovarian function suppression in women with node-positive breast cancer.Breast cancer research and treatment
ÁttekintésBrain Metastasis of Triple-Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies.The breast journal
EsetismertetésOrganoid-Guided Precision Salvage Therapy for Advanced Breast Cancer with Multiple Metastases: A Case Report.International journal of women's health
Imlunestrant as Monotherapy or in Combination with Abemaciclib in ER+, HER2- Advanced Breast Cancer: Chinese Subgroup Analysis of the Phase III Randomized EMBER-3 Study.Targeted oncology
Real-world patient experiences in HR+/HER2- metastatic breast cancer: a study of symptom and side effect reporting by patients and physicians.Breast cancer research and treatment
Subtype conversion and metastatic timing in breast cancer liver metastasis.World journal of surgical oncology
Randomizált vizsgálatCardioprotective Effects of Low-Dose Bisoprolol Against Anthracycline-Induced Subclinical Cardiotoxicity in Breast Cancer: A Triple-Blind Randomized Controlled Trial Using Advanced Echocardiographic Parameters.Iranian journal of medical sciences
PreprintFORESEE: A prospective feasibility trial of functional precision oncology for metastatic breast cancer patients.medRxiv : the preprint server for health sciences
PreprintBreast Cancer Evaluation and Targeted Investigational Therapy (BEAT-IT): A Pilot Prospective Tissue-Testing Study for Breast Cancer Clinical Trial Enrollment.Research square
Multicenter Retrospective Study of the Impact of Localized Therapy on Prognosis in Patients With Oligometastatic Solid Tumors.Cancer medicine
PreprintPhase II study of pembrolizumab plus nab-paclitaxel in Hormone Receptor-positive, HER2- negative metastatic breast cancer: clinical and molecular insights into response.Research square
Efficacy and Safety of Datopotamab Deruxtecan From a Single-Institution Experience in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer After Multiple Prior Therapies Including Antibody-Drug Conjugates.Cancer medicine
Development and internal validation of a nomogram for predicting short- and long-term overall survival in patients with breast cancer liver metastasis: a SEER-based prognostic study.Translational cancer research
Development of an algorithm to support cancer registry registration by identifying patients with metachronous metastases after primary breast cancer.ESMO real world data and digital oncology
ÁttekintésTwo Niches, One Disease: Brain and Leptomeningeal Metastases in Breast Cancer: A Narrative Review.Breast cancer (Dove Medical Press)
PreprintEvasion of Hepatic ILC1 Immunosurveillance Drives Breast Cancer Liver Metastasis.bioRxiv : the preprint server for biology
Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 - metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study.Breast cancer (Tokyo, Japan)
2026 Key European Guideline Changes for Metastatic Breast Cancer and Their Impact on Practice-Commentary Based on a Virtual Focus Group.Clinical breast cancer
Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05.Future oncology (London, England)
Male breast cancer in Northern Tanzania: Clinicopathology and predictors of two-year survival (2016-2022).PloS one
Preclinical Evaluation of cRGD-Functionalized Lipid-Polymer Hybrid Nanocarriers for Anti-VEGF Gene Therapy in Triple-Negative Breast Cancer.Drug development research
Magnetic Resonance Imaging and Mammography Outcomes by Advanced Breast Cancer Risk.JAMA network open
Claudin-1 re-expression as a therapeutic strategy in Triple-negative breast cancer: transcriptional regulation.Molecular biology reports
PreprintTargeting MK2-Driven Stromal Senescence Sensitizes Breast Cancer Bone Metastasis to Immunotherapy.bioRxiv : the preprint server for biology
ÁttekintésImmune remodeling of breast tumor-draining lymph nodes: antigen-presenting cell dysfunction, regulatory T-cell expansion, and premetastatic niche formation.Frontiers in immunology
Treatment outcomes and quality of life with palbociclib in patients with advanced breast cancer who also have other medical conditions: a plain language summary of findings from POLARIS.Future oncology (London, England)
EsetismertetésAnti-trophoblast Cell-Surface Antigen 2 (TROP2)-Based Therapy for Concurrent Breast and Thyroid Malignancies.Cureus
EsetismertetésCase Report: Prolonged survival following multimodal treatment of leptomeningeal metastases in triple-negative glycogen-rich clear cell breast carcinoma.Frontiers in oncology
ÁttekintésHepatic surgery for breast cancer liver metastases in the modern systemic therapy era: narrative review of evidence, patient selection, and a multidisciplinary decision framework.Chinese clinical oncology
ÁttekintésBeyond Metastatic Lymphadenopathy in Breast Cancer: Approach to Axillary Masses.Radiographics : a review publication of the Radiological Society of North America, Inc